Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s00401-015-1398-z.

Title:
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas | Acta Neuropathologica
Description:
Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of tumors. The role of tumor grade and mitotic index in patient outcome has not been evaluated following stratification by IDH mutation status. To address this, we interrogated 558 WHO grade II–III diffuse gliomas for IDH1/2 mutations and investigated the prognostic impact of WHO grade within IDH-mutant and IDH-wild type tumor subsets independently. The prognostic impact of grade was modest in IDH-mutant [hazard ratio (HR) = 1.21, 95 % confidence interval (CI) = 0.91–1.61] compared to IDH-wild type tumors (HR = 1.74, 95 % CI = 0.95–3.16). Using a dichotomized mitotic index cut-off of 4/1000 tumor cells, we found that while mitotic index was significantly associated with outcome in IDH-wild type tumors (log-rank p < 0.0001, HR = 4.41, 95 % CI = 2.55–7.63), it was not associated with outcome in IDH-mutant tumors (log-rank p = 0.5157, HR = 1.10, 95 % CI = 0.80–1.51), and could demonstrate a statistical interaction (p < 0.0001) between IDH mutation and mitotic index (i.e., suggesting that the effect of mitotic index on patient outcome is dependent on IDH mutation status). Patient age, an established prognostic factor in diffuse glioma, was significantly associated with outcome only in the IDH-wild type subset, and consistent with prior data, 1p/19q co-deletion conferred improved outcome in the IDH-mutant cohort. These findings suggest that stratification of grade II–III gliomas into subsets defined by the presence or absence of IDH mutation leads to subgroups with distinct prognostic characteristics. Further evaluation of grading criteria and prognostic markers is warranted within IDH-mutant versus IDH-wild type diffuse grade II–III gliomas as independent entities.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We can't tell how the site generates income.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {šŸ”}

pubmed, google, scholar, article, idh, cas, gliomas, cancer, central, van, grade, prognostic, mutations, mutation, glioma, clin, tumors, molecular, anaplastic, aldape, oncol, survival, lowgrade, center, mitotic, diffuse, outcome, wang, classification, university, status, deimling, pathol, doijco, friedman, usa, acta, index, tumor, patients, oligodendroglioma, dois, reifenberger, neuropathol, analysis, wesseling, astrocytomas, zhang, bent, material,

Topics {āœ’ļø}

month download article/chapter idh-wild type tumors elizabeth vera-bolanos idh-wild type subset grade ii–iii gliomas van den bent low-grade diffuse gliomas diffuse low-grade gliomas idh-mutant [hazard ratio bauke ylstraĀ &Ā pieter wesseling central nervous system health/national cancer institute idh wild-type intermediate-grade infiltrating astrocytomas proliferation markers ki-67/mib-1 hemispheric low-grade gliomas low-grade hemispheric gliomas secondary high-grade gliomas supratentorial low-grade glioma cerebral low-grade glioma neuropathology-haarlem consensus guidelines van den berg van essen hf phase iii trial grade ii astrocytomas full article pdf grade ii gliomas ontario cancer institute related subjects mgmt promoter status idh mutation status academic medical center human glioblastoma multiforme newly diagnosed glioblastoma den dunnen wf privacy choices/manage cookies idh-mutant tumors idh-mutant cohort van der valk human anaplastic astrocytomas quantitative microsatellite analysis integrated genomic analysis lower-grade gliomas low-grade astrocytomas idh1 mutant glioblastoma low-grade gliomas lower-grade glioma single-center experience idh mutation leads idh mutation identifies

Questions {ā“}

  • Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, Reifenberger G, Pietsch T, von Deimling A, Loeffler M, Weller M (2011) Molecular markers in low-grade gliomas: predictive or prognostic?

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
         description:Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of tumors. The role of tumor grade and mitotic index in patient outcome has not been evaluated following stratification by IDH mutation status. To address this, we interrogated 558 WHO grade II–III diffuse gliomas for IDH1/2 mutations and investigated the prognostic impact of WHO grade within IDH-mutant and IDH-wild type tumor subsets independently. The prognostic impact of grade was modest in IDH-mutant [hazard ratio (HR)Ā =Ā 1.21, 95Ā % confidence interval (CI)Ā =Ā 0.91–1.61] compared to IDH-wild type tumors (HRĀ =Ā 1.74, 95Ā % CIĀ =Ā 0.95–3.16). Using a dichotomized mitotic index cut-off of 4/1000 tumor cells, we found that while mitotic index was significantly associated with outcome in IDH-wild type tumors (log-rank pĀ <Ā 0.0001, HRĀ =Ā 4.41, 95Ā % CIĀ =Ā 2.55–7.63), it was not associated with outcome in IDH-mutant tumors (log-rank pĀ =Ā 0.5157, HRĀ =Ā 1.10, 95Ā % CIĀ =Ā 0.80–1.51), and could demonstrate a statistical interaction (pĀ <Ā 0.0001) between IDH mutation and mitotic index (i.e., suggesting that the effect of mitotic index on patient outcome is dependent on IDH mutation status). Patient age, an established prognostic factor in diffuse glioma, was significantly associated with outcome only in the IDH-wild type subset, and consistent with prior data, 1p/19q co-deletion conferred improved outcome in the IDH-mutant cohort. These findings suggest that stratification of grade II–III gliomas into subsets defined by the presence or absence of IDH mutation leads to subgroups with distinct prognostic characteristics. Further evaluation of grading criteria and prognostic markers is warranted within IDH-mutant versus IDH-wild type diffuse grade II–III gliomas as independent entities.
         datePublished:2015-02-21T00:00:00Z
         dateModified:2015-02-21T00:00:00Z
         pageStart:585
         pageEnd:596
         sameAs:https://doi.org/10.1007/s00401-015-1398-z
         keywords:
            Diffuse glioma
            IDH
            1p/19q
            Outcome
            WHO grade
            pHH3
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig3_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:129
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Adriana Olar
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Khalida M. Wani
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kristin D. Alfaro-Munoz
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lindsey E. Heathcock
               affiliation:
                     name:Baylor College of Medicine
                     address:
                        name:Baylor College of Medicine, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hinke F. van Thuijl
               affiliation:
                     name:VU University Medical Center
                     address:
                        name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:VU University Medical Center
                     address:
                        name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark R. Gilbert
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Terri S. Armstrong
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Texas Health Science Center
                     address:
                        name:The University of Texas Health Science Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Erik P. Sulman
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel P. Cahill
               affiliation:
                     name:Massachusetts General Hospital
                     address:
                        name:Department of Neurosurgery, Massachusetts General Hospital, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elizabeth Vera-Bolanos
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:Horizon Health
                     address:
                        name:Horizon Health, Lewisville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ying Yuan
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jaap C. Reijneveld
               affiliation:
                     name:VU University Medical Center
                     address:
                        name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bauke Ylstra
               affiliation:
                     name:VU University Medical Center
                     address:
                        name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pieter Wesseling
               affiliation:
                     name:VU University Medical Center
                     address:
                        name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Radboud University Medical Center
                     address:
                        name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kenneth D. Aldape
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:Princess Margaret Cancer Centre and Ontario Cancer Institute
                     address:
                        name:Princess Margaret Cancer Centre and Ontario Cancer Institute, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
      description:Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of tumors. The role of tumor grade and mitotic index in patient outcome has not been evaluated following stratification by IDH mutation status. To address this, we interrogated 558 WHO grade II–III diffuse gliomas for IDH1/2 mutations and investigated the prognostic impact of WHO grade within IDH-mutant and IDH-wild type tumor subsets independently. The prognostic impact of grade was modest in IDH-mutant [hazard ratio (HR)Ā =Ā 1.21, 95Ā % confidence interval (CI)Ā =Ā 0.91–1.61] compared to IDH-wild type tumors (HRĀ =Ā 1.74, 95Ā % CIĀ =Ā 0.95–3.16). Using a dichotomized mitotic index cut-off of 4/1000 tumor cells, we found that while mitotic index was significantly associated with outcome in IDH-wild type tumors (log-rank pĀ <Ā 0.0001, HRĀ =Ā 4.41, 95Ā % CIĀ =Ā 2.55–7.63), it was not associated with outcome in IDH-mutant tumors (log-rank pĀ =Ā 0.5157, HRĀ =Ā 1.10, 95Ā % CIĀ =Ā 0.80–1.51), and could demonstrate a statistical interaction (pĀ <Ā 0.0001) between IDH mutation and mitotic index (i.e., suggesting that the effect of mitotic index on patient outcome is dependent on IDH mutation status). Patient age, an established prognostic factor in diffuse glioma, was significantly associated with outcome only in the IDH-wild type subset, and consistent with prior data, 1p/19q co-deletion conferred improved outcome in the IDH-mutant cohort. These findings suggest that stratification of grade II–III gliomas into subsets defined by the presence or absence of IDH mutation leads to subgroups with distinct prognostic characteristics. Further evaluation of grading criteria and prognostic markers is warranted within IDH-mutant versus IDH-wild type diffuse grade II–III gliomas as independent entities.
      datePublished:2015-02-21T00:00:00Z
      dateModified:2015-02-21T00:00:00Z
      pageStart:585
      pageEnd:596
      sameAs:https://doi.org/10.1007/s00401-015-1398-z
      keywords:
         Diffuse glioma
         IDH
         1p/19q
         Outcome
         WHO grade
         pHH3
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-015-1398-z/MediaObjects/401_2015_1398_Fig3_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:129
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Adriana Olar
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Khalida M. Wani
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kristin D. Alfaro-Munoz
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lindsey E. Heathcock
            affiliation:
                  name:Baylor College of Medicine
                  address:
                     name:Baylor College of Medicine, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hinke F. van Thuijl
            affiliation:
                  name:VU University Medical Center
                  address:
                     name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:VU University Medical Center
                  address:
                     name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark R. Gilbert
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Terri S. Armstrong
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Texas Health Science Center
                  address:
                     name:The University of Texas Health Science Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Erik P. Sulman
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel P. Cahill
            affiliation:
                  name:Massachusetts General Hospital
                  address:
                     name:Department of Neurosurgery, Massachusetts General Hospital, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elizabeth Vera-Bolanos
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:Horizon Health
                  address:
                     name:Horizon Health, Lewisville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ying Yuan
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jaap C. Reijneveld
            affiliation:
                  name:VU University Medical Center
                  address:
                     name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bauke Ylstra
            affiliation:
                  name:VU University Medical Center
                  address:
                     name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pieter Wesseling
            affiliation:
                  name:VU University Medical Center
                  address:
                     name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Radboud University Medical Center
                  address:
                     name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kenneth D. Aldape
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:Princess Margaret Cancer Centre and Ontario Cancer Institute
                  address:
                     name:Princess Margaret Cancer Centre and Ontario Cancer Institute, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:129
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Baylor College of Medicine
      address:
         name:Baylor College of Medicine, Houston, USA
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas Health Science Center
      address:
         name:The University of Texas Health Science Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Massachusetts General Hospital
      address:
         name:Department of Neurosurgery, Massachusetts General Hospital, Boston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Horizon Health
      address:
         name:Horizon Health, Lewisville, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:VU University Medical Center
      address:
         name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:Radboud University Medical Center
      address:
         name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Princess Margaret Cancer Centre and Ontario Cancer Institute
      address:
         name:Princess Margaret Cancer Centre and Ontario Cancer Institute, Toronto, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Adriana Olar
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Khalida M. Wani
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Kristin D. Alfaro-Munoz
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Lindsey E. Heathcock
      affiliation:
            name:Baylor College of Medicine
            address:
               name:Baylor College of Medicine, Houston, USA
               type:PostalAddress
            type:Organization
      name:Hinke F. van Thuijl
      affiliation:
            name:VU University Medical Center
            address:
               name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:VU University Medical Center
            address:
               name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Mark R. Gilbert
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Terri S. Armstrong
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:The University of Texas Health Science Center
            address:
               name:The University of Texas Health Science Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Erik P. Sulman
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Daniel P. Cahill
      affiliation:
            name:Massachusetts General Hospital
            address:
               name:Department of Neurosurgery, Massachusetts General Hospital, Boston, USA
               type:PostalAddress
            type:Organization
      name:Elizabeth Vera-Bolanos
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:Horizon Health
            address:
               name:Horizon Health, Lewisville, USA
               type:PostalAddress
            type:Organization
      name:Ying Yuan
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Jaap C. Reijneveld
      affiliation:
            name:VU University Medical Center
            address:
               name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Bauke Ylstra
      affiliation:
            name:VU University Medical Center
            address:
               name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Pieter Wesseling
      affiliation:
            name:VU University Medical Center
            address:
               name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:Radboud University Medical Center
            address:
               name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
               type:PostalAddress
            type:Organization
      name:Kenneth D. Aldape
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:Princess Margaret Cancer Centre and Ontario Cancer Institute
            address:
               name:Princess Margaret Cancer Centre and Ontario Cancer Institute, Toronto, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Baylor College of Medicine, Houston, USA
      name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
      name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
      name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:The University of Texas Health Science Center, Houston, USA
      name:Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Neurosurgery, Massachusetts General Hospital, Boston, USA
      name:Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Horizon Health, Lewisville, USA
      name:Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
      name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
      name:Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
      name:Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
      name:Department of Pathology, G1.3510, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Princess Margaret Cancer Centre and Ontario Cancer Institute, Toronto, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(319)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

4.55s.